Digital Evidence Base

Trusted Knowledge for Informed Decisions

Filters
SDGs
Priority Areas
Research Outcomes
Document Type
Year
4019 results found
Show:
The frequency and precipitating factors for breakthrough seizures among patients with epilepsy in Uganda
Kaddumukasa M, Katabira E, Matovu S
2013
DOI: 10.1186/1471-2377-13-182

Background: Epilepsy is one of the major brain disorders worldwide. Breakthrough seizures carry a heavy burdenof epilepsy, with increased morbidity and risk of premature mortality. Several factors have been suggested …

Abstract
Neurosurgical Decision-Making and Ethical Considerations in the Treatment of Traumatic Brain Injury
Hughes Jasmine
2022

Globally, disparities in the availability of surgical care are prevalent, and for specialty care such as neurosurgery, services are typically scarce to non-existent. In low-and-middle-income countries, most medical centers have …

Abstract
Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response
Goodridge A, Cueva C, Lahiff M, Muzanye G, Johnson JL, Nahid P, Riley LW
2012
DOI: 10.1016/j.tube.2012.02.004

Standard methods to monitor tuberculosis (TB) treatment response rely on sputum microscopy and culture conversion. Alternatives to these methods are needed for those patients whose sputum tests are smear or …

Abstract
Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients
HuangLiusheng, Mwebaza Norah, Kajubi Richard, Marzan Florence, Forsman Camilla, Parikh Sunil, Aweeka Francesca T
2018
DOI: https://doi.org/10.1371%2Fjournal.pone.0202082

BackgroundLumefantrine is a long-acting antimalarial drug with an elimination half-life of over 3 days and protein binding of 99 percent. Correlation of lumefantrine concentrations from capillary plasma via fingerprick (Cc) …

Abstract
Anti-Platelet Drugs; Pharmacogenomics and Stent Thrombosis: What's New?
Benjamin J
2010

Stent thrombosis is a catastrophic complication of percutaneous coronary intervention (PCI) and is associated with a mortality of 25 to 40. The perception that stent thrombosis is very low in …

Abstract
An Epidemiologic Investigation of Physical Activity and Breast Cancer Risk in Africa
Ndom P, Gakwaya A, Huo DZ, Hou NQ, Jombwe J, Ogundiran T, Ademola A, Morhason-Bello I, Ojengbede O
2014
DOI: 10.1158/1055-9965.EPI-14-0675

Background: Physical activity (PA) is modifiable and linked to decreased breast cancer risk but its impact has not been investigated among indigenous African populations.Methods: From 2011 to 2013, 558 cases …

Abstract
"Our Hands Are Tied Up": Current State of Safer Conception Services Suggests the Need for an Integrated Care Model
Beyeza-Kashesya J, Wagner G, Goggin K, Mindry D, Finocchario-Kessler S, Wanyenze R, Nabiryo C
2014
DOI: 10.1080/07399332.2014.920023

We conducted in-depth interviews with a variety of health care providers (n = 33) in Uganda to identify current services that could support and act as barriers to the provision …

Abstract
Corning HYPERFlask® for viral amplification and production of diagnostic reagents
KearneyBrian J., Voorhees Matthew A., Williams Priscilla L., Olschner Scott P., Rossi Cynthia A., Schoepp Randal J.
2017

MEDLINE Abstract: Viral preparations are essential components in diagnostic research and development. The production of large quantities of virus traditionally is done by infecting numerous tissue culture flasks or roller …

Abstract
Apabetalone downregulates fibrotic, inflammatory and calcific processes in renal mesangial cells which may contribute to reduced cardiac events observed in ckd patients
Gilham D., Fu L., Rakai B., Wasiak S., Tsujikawa L., Halliday C., Sarsons C., Stotz S., Jahagirdar R., Johansson J., Sweeney M., Wong N., Kalantar-Zadeh K., Kulikowski E.
2021
DOI: 10.1093/ndt/gfab078.008

BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …

Abstract
AI Research Assistant
AI-powered research assistance. Uses the Digital Evidence Base as the Knowledge source.